首页> 外文期刊>Antibiotics >Current Issues and Perspectives in Patients with Possible Sepsis at Emergency Departments
【24h】

Current Issues and Perspectives in Patients with Possible Sepsis at Emergency Departments

机译:急诊科可能败血症患者的最新问题和观点

获取原文
           

摘要

In the area of Emergency Room (ER), many patients present criteria compatible with a SIRS, but only some of them have an associated infection. The new definition of sepsis by the European Society of Intensive Care Medicine and the Society of Critical Care Medicine (2016), revolutionizes precedent criteria, overcoming the concept of SIRS and clearly distinguishing the infection with the patient’s physiological response from the symptoms of sepsis. Another fundamental change concerns the recognition method: The use of SOFA (Sequential-Sepsis Related-Organ Failure Assessment Score) as reference score for organ damage assessment. Also, the use of the qSOFA is based on the use of three objective parameters: Altered level of consciousness (GCS 15 or AVPU), systolic blood pressure ≤ 100 mmHg, and respiratory rate ≥ 22/min. If patients have at least two of these altered parameters in association with an infection, then there is the suspicion of sepsis. In these patients the risk of death is higher, and it is necessary to implement the appropriate management protocols, indeed the hospital mortality rate of these patients exceeds 40%. Patients with septic shock can be identified by the association of the clinical symptoms of sepsis with persistent hypotension, which requires vasopressors to maintain a MAP of 65 mmHg, and serum lactate levels 18 mg/dL in despite of an adequate volume resuscitation. Then, patient first management is mainly based on: (1) Recognition of the potentially septic patient (sepsis protocol-qSOFA); (2) Laboratory investigations; (3) Empirical antibiotic therapy in patients with sepsis and septic shock. With this in mind, the authors discuss the most important aspects of the sepsis in both adults and infants, and also consider the possible treatment according current guidelines. In addition, the possible role of some nutraceuticals as supportive therapy in septic patient is also discussed.
机译:在急诊室(ER)区域,许多患者提出的标准与SIRS兼容,但只有其中一部分患者伴有相关感染。欧洲重症监护医学学会和重症监护医学学会对脓毒症的新定义(2016年)彻底改变了先例标准,克服了SIRS的概念,并清楚地将感染的患者的生理反应与脓毒症症状区分开来。另一个基本变化涉及识别方法:使用SOFA(顺序脓毒症相关器官衰竭评估评分)作为器官损害评估的参考评分。同样,qSOFA的使用基于三个客观参数的使用:意识改变(GCS <15或AVPU),收缩压≤100 mmHg和呼吸频率≥22 / min。如果患者至少有两个与感染相关的改变的参数,则有败血症的嫌疑。在这些患者中,死亡风险更高,并且有必要实施适当的管理方案,实际上这些患者的医院死亡率超过40%。败血症性休克患者可通过脓毒症的临床症状与持续性低血压相关联来确定,尽管有足够的容量复苏,这仍需要血管加压药将MAP维持在65 mmHg,血清乳酸水平> 18 mg / dL。然后,患者的优先处理主要基于:(1)对潜在败血症患者的识别(败血症协议-qSOFA); (2)实验室调查; (3)败血症和脓毒性休克患者的经验性抗生素治疗。考虑到这一点,作者讨论了脓毒症在成人和婴儿中最重要的方面,并根据现行指南考虑了可能的治疗方法。此外,还讨论了某些营养药在脓毒症患者中作为支持疗法的可能作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号